BioSpace News Archive

Orexo AB, has entered into an exclusive licensing agreement with Accord Healthcare, for the commercialisation of ZUBSOLV® and naloxone ) sublingual tablet.

Veristat, a global clinical research organization, was named among the Top Patient Recruitment Companies of 2020 by Pharma Tech Outlook.

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, announced results presented at the 62nd annual meeting American Society of Hematology, which provide in vivo biomarker evidence linking remestemcel-L’s immunomodulatory activity to survival outcomes in children with steroid-refractory acute graft versus host disease.

Accelerates milestone payments to Nabriva, including fourth quarter 2020payment of $1 million

Imara Inc., a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, announced that it presented two case reports from the ongoing IMR-687 Phase 2a open label extension clinical trial in adult patients with sickle cell disease at the 62nd American Society of Hematology Annual Meeting and Exposition.

Grant will support clinical studies in patients with post-traumatic stress disorder related to alcohol and substance abuse

Completion of dedicated CGMP suite enhances manufacturing readiness and secures supply chain control to support lead CNS gene therapy product candidates as they advance through clinical trials to commercialization

Chimerix, a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, announced that the U.S. Food and Drug Administration has accepted the filing of a New Drug Application for brincidofovir as a medical countermeasure for smallpox.

OTCQB: PetVivo Holdings, Inc. an emerging biomedical device company operating in the $19B veterinary market announced it will be exhibiting at the American Association of Equine Practitioners Virtual Convention and Trade Show from December 5th to December 8th, 2020 that can be accessed online at https://convention.aaep.org/.

Amicus Therapeutics, a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, announced that it has been nationally recognized as a Great Place to Work-Certified™ Company in 2020.